⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AQST News
Aquestive Therapeutics, Inc. Common Stock
AQST DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST
accessnewswire.com
AQST
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
prnewswire.com
AQST
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
AQST
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AQST
Class Action Reminder from Pomerantz LLP for Shareholders of Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
AQST Deadline: AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
AQST
Class Action Reminder from Pomerantz LLP for Investors of Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AQST
AQST DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST
accessnewswire.com
AQST
AQST DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 4 Deadline in Securities Class Action – AQST
globenewswire.com
AQST